{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:24:28Z","timestamp":1794536668441,"version":"4.9.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403533"],"award-info":[{"award-number":["82403533"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273299"],"award-info":[{"award-number":["82273299"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372056"],"award-info":[{"award-number":["82372056"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M763761"],"award-info":[{"award-number":["2024M763761"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2024A03J1019"],"award-info":[{"award-number":["2024A03J1019"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2023A04J2217"],"award-info":[{"award-number":["2023A04J2217"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijbiomac.2025.143014","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:19:27Z","timestamp":1744165167000},"page":"143014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P3","title":["Single-cell and bulk RNA-sequence identify an immune-derived lncRNA-mRNA signature for predicting clinical outcomes and immunotherapeutic response of prostate cancer"],"prefix":"10.1016","volume":"309","author":[{"given":"Ren","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiocheng","family":"Un","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renxuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weide","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingwu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijbiomac.2025.143014_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.143014_bb0010","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.annonc.2020.06.011","article-title":"Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Parker","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.143014_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122469","article-title":"Nanotherapeutics for prostate cancer treatment: a comprehensive review","volume":"305","author":"Hu","year":"2024","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.143014_bb0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/bph.15300","article-title":"Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it","volume":"178","author":"Wang","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.143014_bb0025","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41585-023-00834-y","article-title":"Intratumoural immunotherapy plus focal thermal ablation for localized prostate cancer","volume":"21","author":"Seguier","year":"2024","journal-title":"Nat. Rev. Urol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.143014_bb0030","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.eururo.2022.01.028","article-title":"Adverse events of immune checkpoint inhibitors therapy for urologic cancer patients in clinical trials: a collaborative systematic review and meta-analysis","volume":"81","author":"Wu","year":"2022","journal-title":"Eur. Urol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.143014_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2023.10.006","article-title":"Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer","volume":"41","author":"Hawley","year":"2023","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.143014_bb0040","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41591-023-02284-w","article-title":"Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial","volume":"29","author":"Shenderov","year":"2023","journal-title":"Nat. Med."},{"issue":"694","key":"10.1016\/j.ijbiomac.2025.143014_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade5855","article-title":"Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancer","volume":"15","author":"Wang","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.143014_bb0050","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jamaoncol.2023.6817","article-title":"Tumor mutational burden in metastatic castration-resistant prostate cancer and response to checkpoint inhibition","volume":"10","author":"Zang","year":"2024","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ijbiomac.2025.143014_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2024.04.026","article-title":"The role of microsatellite instability\/DNA mismatch repair deficiency and tumor mutational burden as biomarkers in predicting response to immunotherapy in castration-resistant prostate cancer","author":"Klumper","year":"2024","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.143014_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41585-020-00400-w","article-title":"Genomic and phenotypic heterogeneity in prostate cancer","volume":"18","author":"Haffner","year":"2021","journal-title":"Nat. Rev. Urol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.143014_bb0065","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nrurol.2012.185","article-title":"The complexity of prostate cancer: genomic alterations and heterogeneity","volume":"9","author":"Boyd","year":"2012","journal-title":"Nat. Rev. Urol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.143014_bb0070","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.eururo.2018.06.005","article-title":"Spatial intratumor genomic heterogeneity within localized prostate cancer revealed by single-nucleus sequencing","volume":"74","author":"Su","year":"2018","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.143014_bb0075","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.it.2023.12.005","article-title":"Lnc-ing RNA to intestinal homeostasis and inflammation","volume":"45","author":"Fitzgerald","year":"2024","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.143014_bb0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143014_bb0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41419-024-06450-x","article-title":"FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2alpha blockade by facilitating LDHA phosphorylation","volume":"15","author":"Liu","year":"2024","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.143014_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245638","article-title":"Pixelwise H-score: a novel digital image analysis-based metric to quantify membrane biomarker expression from immunohistochemistry images","volume":"16","author":"Ram","year":"2021","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.143014_bb0095","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrc.2015.21","article-title":"BRCAness revisited","volume":"16","author":"Lord","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.143014_bb0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","article-title":"Tumor mutational load predicts survival after immunotherapy across multiple cancer types","volume":"51","author":"Samstein","year":"2019","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.143014_bb0105","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41587-022-01331-0","article-title":"FDA approves anti-LAG3 checkpoint","volume":"40","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.143014_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008799","article-title":"Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy","volume":"12","author":"Jeon","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.143014_bb0115","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003776","article-title":"Phase I\/II study of the LAG-3 inhibitor ieramilimab (LAG525) +\/- anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies","volume":"10","author":"Schoffski","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"33","key":"10.1016\/j.ijbiomac.2025.143014_bb0120","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1038\/onc.2015.494","article-title":"SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment","volume":"35","author":"Sun","year":"2016","journal-title":"Oncogene"},{"issue":"7598","key":"10.1016\/j.ijbiomac.2025.143014_bb0125","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature17392","article-title":"sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance","volume":"532","author":"Kaur","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.143014_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2020.08.007","article-title":"Nivolumab plus ipilimumab for metastatic castration-resistant prostate cancer: preliminary analysis of patients in the CheckMate 650 trial","volume":"38","author":"Sharma","year":"2020","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.143014_bb0135","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.euo.2022.04.004","article-title":"Immune biomarkers in metastatic castration-resistant prostate cancer","volume":"5","author":"Fenor de la Maza","year":"2022","journal-title":"Eur. Urol. Oncol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.143014_bb0140","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/1078-0432.CCR-21-0299","article-title":"Single-cell analysis reveals EP4 as a target for restoring T-cell infiltration and sensitizing prostate cancer to immunotherapy","volume":"28","author":"Peng","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143014_bb0145","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/s41467-021-21615-4","article-title":"Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling","volume":"12","author":"Brady","year":"2021","journal-title":"Nat. Commun."},{"issue":"18","key":"10.1016\/j.ijbiomac.2025.143014_bb0150","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143014_bb0155","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab504","article-title":"Tumor immune microenvironment lncRNAs","volume":"23","author":"Park","year":"2022","journal-title":"Brief. Bioinform."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.143014_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107241","article-title":"The immune checkpoint receptor LAG3: structure, function, and target for cancer immunotherapy","volume":"300","author":"Mariuzza","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"7710","key":"10.1016\/j.ijbiomac.2025.143014_bb0165","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41586-018-0206-z","article-title":"Induction and transcriptional regulation of the co-inhibitory gene module in T cells","volume":"558","author":"Chihara","year":"2018","journal-title":"Nature"},{"issue":"7801","key":"10.1016\/j.ijbiomac.2025.143014_bb0170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41586-020-2135-x","article-title":"A genomic and epigenomic atlas of prostate cancer in Asian populations","volume":"580","author":"Li","year":"2020","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.143014_bb0175","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrg3539","article-title":"Emerging patterns of somatic mutations in cancer","volume":"14","author":"Watson","year":"2013","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143014_bb0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.143014_bb0185","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.trecan.2020.05.011","article-title":"DNA damage repair deficiency in prostate cancer","volume":"6","author":"Burdak-Rothkamm","year":"2020","journal-title":"Trends Cancer"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025035664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025035664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:44:34Z","timestamp":1782902674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025035664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":37,"alternative-id":["S0141813025035664"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.143014","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-cell and bulk RNA-sequence identify an immune-derived lncRNA-mRNA signature for predicting clinical outcomes and immunotherapeutic response of prostate cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.143014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"143014"}}